Literature DB >> 15381553

Dermatitis and the newborn rash of hyper-IgE syndrome.

Cheryl Lee D Eberting1, Joie Davis, Jennifer M Puck, Steven M Holland, Maria L Turner.   

Abstract

OBJECTIVE: To characterize the dermatitis, the newborn rash, and cutaneous findings in hyper-IgE syndrome, also known as Job's syndrome.
DESIGN: Prospective and retrospective evaluation and treatment of cutaneous manifestations in patients with a clinical diagnosis of hyper-IgE syndrome (HIES). Analysis of the newborn rash encountered in this population.
SETTING: Dermatology clinic at the National Institutes of Health, Bethesda, Md. PATIENTS: Forty-three patients seen in our clinic between January 1998 and August 2003 who had a clinical diagnosis of HIES.
INTERVENTIONS: The UK Working Party's Diagnostic Criteria for Atopic Dermatitis were used to assess for atopic dermatitis in this population. To assess the newborn rash, we performed a retrospective chart review and an in-person or telephone interview of the parent or caregiver of each patient.
RESULTS: Twenty-eight (65%) of 43 patients fulfilled the criteria for atopic dermatitis. Thirty-five (81%) of 43 patients reported a newborn rash. Eight (19%) of 43 were born with the rash; 23 (53%) of 43 had acquired the rash within 7 days; 32 (74%) of 43 within 14 days; 34 (79%) of 43 within 30 days; and 35 (81%) of 43 had the rash within 35 days of birth.
CONCLUSIONS: The dermatitis in HIES resembles classic atopic dermatitis but may have distinctive features. A newborn rash is almost always a presenting sign of HIES. After the newborn period, skin findings include retroauricular fissures, external otitis, infected dermatitis of the axillae and groin, folliculitis of the upper back and shoulders, cutaneous abscesses, mucocutaneous candidiasis, and in some patients pitted scarring of the face.

Entities:  

Mesh:

Year:  2004        PMID: 15381553     DOI: 10.1001/archderm.140.9.1119

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


  20 in total

1.  Cutaneous manifestations of DOCK8 deficiency syndrome.

Authors:  Emily Y Chu; Alexandra F Freeman; Huie Jing; Edward W Cowen; Joie Davis; Helen C Su; Steven M Holland; Maria L Chanco Turner
Journal:  Arch Dermatol       Date:  2011-09-19

Review 2.  Hyper-IgE syndrome update.

Authors:  Kathryn J Sowerwine; Steven M Holland; Alexandra F Freeman
Journal:  Ann N Y Acad Sci       Date:  2012-01-23       Impact factor: 5.691

Review 3.  Atopic dermatitis in children: clinical features, pathophysiology, and treatment.

Authors:  Jonathan J Lyons; Joshua D Milner; Kelly D Stone
Journal:  Immunol Allergy Clin North Am       Date:  2014-11-21       Impact factor: 3.479

Review 4.  Atopic Dermatitis and Allergic Urticaria: Cutaneous Manifestations of Immunodeficiency.

Authors:  Martin Robert Gaudinski; Joshua D Milner
Journal:  Immunol Allergy Clin North Am       Date:  2016-10-28       Impact factor: 3.479

Review 5.  Eosinophilia Associated with Disorders of Immune Deficiency or Immune Dysregulation.

Authors:  Kelli W Williams; Joshua D Milner; Alexandra F Freeman
Journal:  Immunol Allergy Clin North Am       Date:  2015-08       Impact factor: 3.479

6.  Hemoptysis in a Patient with Elevated Immunoglobulin E.

Authors:  Yael Gernez; Angela Tsuang; Tukisa D Smith; Khurram Shahjehan; Yiqun Hui; Paul J Maglione; Charlotte Cunningham-Rundles
Journal:  J Allergy Clin Immunol Pract       Date:  2016-09-29

Review 7.  Primary immunodeficiency update: Part I. Syndromes associated with eczematous dermatitis.

Authors:  Dominique C Pichard; Alexandra F Freeman; Edward W Cowen
Journal:  J Am Acad Dermatol       Date:  2015-09       Impact factor: 11.527

Review 8.  The hyper-IgE syndromes.

Authors:  Alexandra F Freeman; Steven M Holland
Journal:  Immunol Allergy Clin North Am       Date:  2008-05       Impact factor: 3.479

9.  Investigation of Skin Barrier Functions and Allergic Sensitization in Patients with Hyper-IgE Syndrome.

Authors:  Gábor Mócsai; Krisztián Gáspár; Zsolt Dajnoki; Beáta Tóth; Edit Gyimesi; Tamás Bíró; László Maródi; Andrea Szegedi
Journal:  J Clin Immunol       Date:  2015-10-09       Impact factor: 8.317

Review 10.  Hyper-IgE Syndromes and the Lung.

Authors:  Alexandra F Freeman; Kenneth N Olivier
Journal:  Clin Chest Med       Date:  2016-06-10       Impact factor: 2.878

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.